COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Relationship Between Ca Intake , Blood Level of Ca, PTH, TSH, Vitamin D, and Urine Ca, P and Cardiac Calcium Scoring (TSHPTHCA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02035033
Recruitment Status : Unknown
Verified January 2014 by Nariman Saba Khazan, Carmel Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : January 14, 2014
Last Update Posted : January 14, 2014
Sponsor:
Information provided by (Responsible Party):
Nariman Saba Khazan, Carmel Medical Center

Brief Summary:
Osteoporosis (op) is a disorder of bone characterized by reduced mineral density and bone mass. The first step in the prevention and treatment of Op is ensuring adequate intake of calcium and vitamin D . While calcium supplementations clearly slow bone loss in both sexes,their effects on fracture risk are less certain. In contrast to the above a recent randomized, placebo controlled trial in 1471 postmenopausal women (mean age 74) reported in the BMJ (2 February 2008) found an increased rate of vascular events in healthy older women receiving calcium supplementation. The mechanism is not clear .we are trying to identify a possible correlation between calcium intake and calcium cardiac scoring .

Condition or disease
Disorders of Phosphorus and Calcium Metabolism

Show Show detailed description

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 500 participants
Time Perspective: Prospective
Target Follow-Up Duration: 1 Day
Official Title: The Relationship Between Calcium and Cardiac Calcium Scoring
Study Start Date : January 2014
Estimated Primary Completion Date : December 2015
Estimated Study Completion Date : February 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Calcium

Group/Cohort
low calcium supplement
low calcium supplement
Calcium intake 500-1000 mg per day
Calcium intake 500-1000 mg per day
Calcium intake above 1000 mg per day
Calcium intake above 1000 mg per day



Primary Outcome Measures :
  1. The safety of calcium intake for heart [ Time Frame: 2 years frame ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
participants how recent or planned cardiac CT in the Carmel hospital.
Criteria

Inclusion Criteria:

Male and Female. Aged 50-80 years. Hebrew speakers -

Exclusion Criteria:

- Below age 50 years. Above age 80 years. Previous cardiac surgery . Inadequate cardiac CT study


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02035033


Contacts
Layout table for location contacts
Contact: Nariman Saba Khazan, MD 972544727672 hazan@clalit.org.il

Sponsors and Collaborators
Carmel Medical Center
Investigators
Layout table for investigator information
Study Chair: Nathan Peled, Prof. Clalit Health Services
Additional Information:

Layout table for additonal information
Responsible Party: Nariman Saba Khazan, Head of Endocrinology Department - Lin, Carmel Medical Center
ClinicalTrials.gov Identifier: NCT02035033    
Other Study ID Numbers: CMC-13-0003-CTIL
First Posted: January 14, 2014    Key Record Dates
Last Update Posted: January 14, 2014
Last Verified: January 2014